Runben Biotechnology Co Ltd (603193)

Currency in CNY
18.91
-0.74(-3.77%)
Closed·
603193 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.8620.12
52 wk Range
17.7737.15
Key Statistics
Bid/Ask
18.91 / 18.93
Prev. Close
19.65
Open
19.56
Day's Range
18.86-20.12
52 wk Range
17.77-37.15
Volume
3.5M
Average Volume (3m)
3.76M
1-Year Change
-32.8718%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603193 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
32.98
Upside
+74.41%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 32.98
(+74.41% Upside)

Earnings

Latest Release
23/04/2026
EPS / Forecast
0.13 / --
Revenue / Forecast
267M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.80%
Dividend Yield
2.34%
Industry Median 3.04%
Annualised payout
0.46
Paid annually
5-Years Growth
-
Growth Streak

Compare 603193 to Peers and Sector

Metrics to compare
603193
Peers
Sector
Relationship
P/E Ratio
23.7x24.9x11.5x
PEG Ratio
4.330.110.03
Price/Book
3.4x2.3x1.5x
Price / LTM Sales
4.9x2.3x0.9x
Upside (Analyst Target)
72.1%24.1%24.5%
Fair Value Upside
Unlock20.1%14.0%Unlock

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, infant care products, and essential oil products. The company also sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 1993 and is based in Guangzhou, China.

Employees
1018
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
8.48M2.10%160.39M
Other Institutional Investors
210.00M51.90%3.97B
Public Companies & Retail Investors
186.12M46.00%3.52B
Total
404.59M100.00%7.65B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Guangzhou Zhuofan Investment Holding Co., Ltd44.58%180,387,0003,411,118
Guangzhou Zhuofan Chengguang Investment Consulting Partnership (Limited Partnership)5.29%21,420,000405,052

People Also Watch

9.03
000989
-6.52%
36.00
603288
-0.88%

FAQ

What Is the Runben Biotechnology (Shanghai: 603193) Share Price Today?

The Runben Biotechnology stock price today is 18.91 CNY.

What Stock Exchange Does Runben Biotechnology (603193) Trade On?

Runben Biotechnology is listed and trades on the Shanghai Stock Exchange.

What Is the Ticker (Stock Symbol) for Runben Biotechnology?

The stock symbol (also called a 'ticker') for Runben Biotechnology is "603193."

Does Runben Biotechnology Pay Dividends? What’s The Current 603193 Dividend Yield?

Yes, 603193 Pays Dividends to its Shareholders. The current Runben Biotechnology dividend yield is 2.34%.

What Is the Current Runben Biotechnology Market Capitalisation?

As of today, Runben Biotechnology (Shanghai: 603193) market cap is 7.65B CNY.

What Is Runben Biotechnology's (603193) Earnings Per Share (TTM)?

The Runben Biotechnology EPS is currently 0.80 (Trailing Twelve Months).

When Is the Next Runben Biotechnology Earnings Date?

Runben Biotechnology's next earnings report will be released on 21/08/2026.

Is 603193 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Runben Biotechnology moving averages and other technical indicators, the daily buy/sell signal for 603193 stock is Sell.

How Many Times Has Runben Biotechnology Stock Split?

Runben Biotechnology has split 0 times. (See the 603193 stock split history page for full effective split date and price information.)

How Many Employees Does Runben Biotechnology Have?

Runben Biotechnology has 1018 employees, based on their latest Companies House report.

What is the current trading status of Runben Biotechnology (Shanghai: 603193)?

As of 18/07/2026, Runben Biotechnology (603193) is trading at a share price of 18.91 CNY, with a previous close of 19.65 CNY. The stock has fluctuated within a day range of 18.86 CNY to 20.12 CNY, while its 52-week range spans from 17.77 CNY to 37.15 CNY.

What Is Runben Biotechnology (603193) Price Target According to Analysts?

The average 12-month price target for Runben Biotechnology is 32.98 CNY, with a high estimate of 36.4 CNY and a low estimate of 30 CNY. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +74.41% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.